Vor Historical Balance Sheet

VOR Stock  USD 1.08  0.03  2.70%   
Trend analysis of Vor Biopharma balance sheet accounts such as Total Assets of 151.6 M, Short Long Term Debt Total of 25.4 M, Other Current Liabilities of 13.2 M or Total Current Liabilities of 10.8 M provides information on Vor Biopharma's total assets, liabilities, and equity, which is the actual value of Vor Biopharma to its prevalent stockholders. By breaking down trends over time using Vor Biopharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Vor Biopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vor Biopharma is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

About Vor Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Vor Biopharma at a specified time, usually calculated after every quarter, six months, or one year. Vor Biopharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Vor Biopharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Vor currently owns. An asset can also be divided into two categories, current and non-current.

Vor Biopharma Balance Sheet Chart

At this time, Vor Biopharma's Other Stockholder Equity is relatively stable compared to the past year. As of 03/02/2025, Property Plant And Equipment Gross is likely to grow to about 70.3 M, while Short and Long Term Debt Total is likely to drop slightly above 25.4 M.

Total Assets

Total assets refers to the total amount of Vor Biopharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vor Biopharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Vor Biopharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vor Biopharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most accounts from Vor Biopharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Vor Biopharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.At this time, Vor Biopharma's Other Stockholder Equity is relatively stable compared to the past year. As of 03/02/2025, Property Plant And Equipment Gross is likely to grow to about 70.3 M, while Short and Long Term Debt Total is likely to drop slightly above 25.4 M.
 2022 2023 2024 2025 (projected)
Short and Long Term Debt Total38.9M35.7M41.0M25.4M
Total Assets299.4M198.1M227.8M151.6M

Vor Biopharma balance sheet Correlations

0.90.710.781.00.90.890.82-0.49-0.860.740.820.90.990.810.930.970.90.920.950.88-0.340.99-0.040.990.24
0.90.810.780.870.850.930.9-0.18-0.920.70.590.930.860.940.970.790.890.940.790.93-0.430.850.080.850.06
0.710.810.80.680.840.910.71-0.05-0.940.570.50.920.660.850.820.60.890.830.590.92-0.760.660.060.65-0.01
0.780.780.80.740.780.830.56-0.08-0.850.450.470.830.730.750.890.670.810.930.720.83-0.380.73-0.060.710.33
1.00.870.680.740.890.870.81-0.54-0.830.740.850.871.00.780.910.990.890.890.960.86-0.331.0-0.061.00.24
0.90.850.840.780.890.920.69-0.25-0.940.510.660.920.890.790.850.880.990.850.910.93-0.620.89-0.30.880.33
0.890.930.910.830.870.920.79-0.14-0.970.690.611.00.860.860.950.80.960.940.791.0-0.630.860.010.850.21
0.820.90.710.560.810.690.79-0.46-0.760.850.730.80.80.930.840.750.740.790.660.78-0.340.80.350.8-0.31
-0.49-0.18-0.05-0.08-0.54-0.25-0.14-0.460.1-0.59-0.86-0.16-0.56-0.22-0.24-0.61-0.2-0.21-0.45-0.12-0.15-0.56-0.22-0.570.23
-0.86-0.92-0.94-0.85-0.83-0.94-0.97-0.760.1-0.57-0.56-0.97-0.82-0.89-0.92-0.77-0.97-0.92-0.79-0.970.6-0.820.09-0.81-0.16
0.740.70.570.450.740.510.690.85-0.59-0.570.810.710.730.670.730.680.570.680.510.66-0.280.730.610.73-0.27
0.820.590.50.470.850.660.610.73-0.86-0.560.810.630.860.580.640.880.650.620.740.6-0.240.860.180.87-0.07
0.90.930.920.830.870.921.00.8-0.16-0.970.710.630.860.870.950.80.960.940.791.0-0.640.860.030.850.18
0.990.860.660.731.00.890.860.8-0.56-0.820.730.860.860.760.890.990.880.880.960.85-0.321.0-0.061.00.25
0.810.940.850.750.780.790.860.93-0.22-0.890.670.580.870.760.90.70.830.880.670.86-0.440.760.170.75-0.19
0.930.970.820.890.910.850.950.84-0.24-0.920.730.640.950.890.90.830.890.990.820.94-0.390.890.10.880.16
0.970.790.60.670.990.880.80.75-0.61-0.770.680.880.80.990.70.830.850.810.970.79-0.290.99-0.140.990.28
0.90.890.890.810.890.990.960.74-0.2-0.970.570.650.960.880.830.890.850.890.870.97-0.650.88-0.210.870.28
0.920.940.830.930.890.850.940.79-0.21-0.920.680.620.940.880.880.990.810.890.810.93-0.390.880.070.860.2
0.950.790.590.720.960.910.790.66-0.45-0.790.510.740.790.960.670.820.970.870.810.79-0.290.96-0.340.960.44
0.880.930.920.830.860.931.00.78-0.12-0.970.660.61.00.850.860.940.790.970.930.79-0.650.84-0.010.830.21
-0.34-0.43-0.76-0.38-0.33-0.62-0.63-0.34-0.150.6-0.28-0.24-0.64-0.32-0.44-0.39-0.29-0.65-0.39-0.29-0.65-0.320.11-0.31-0.09
0.990.850.660.731.00.890.860.8-0.56-0.820.730.860.861.00.760.890.990.880.880.960.84-0.32-0.071.00.25
-0.040.080.06-0.06-0.06-0.30.010.35-0.220.090.610.180.03-0.060.170.1-0.14-0.210.07-0.34-0.010.11-0.07-0.07-0.71
0.990.850.650.711.00.880.850.8-0.57-0.810.730.870.851.00.750.880.990.870.860.960.83-0.311.0-0.070.24
0.240.06-0.010.330.240.330.21-0.310.23-0.16-0.27-0.070.180.25-0.190.160.280.280.20.440.21-0.090.25-0.710.24
Click cells to compare fundamentals

Vor Biopharma Account Relationship Matchups

Vor Biopharma balance sheet Accounts

202020212022202320242025 (projected)
Total Assets75.9M242.6M299.4M198.1M227.8M151.6M
Other Current Liab6.1M4.9M4.8M10.9M12.6M13.2M
Total Current Liabilities10.2M10.2M13.1M15.6M17.9M10.8M
Total Stockholder Equity48.3M216.3M250.6M150.7M173.3M122.2M
Net Tangible Assets(17.4M)(59.1M)216.3M250.6M288.2M302.6M
Property Plant And Equipment Net21.8M22.5M57.1M50.1M57.6M60.5M
Net Debt(30.2M)(101.8M)(18.8M)4.3M3.9M4.1M
Retained Earnings(61.2M)(130.1M)(222.2M)(340.1M)(306.1M)(290.8M)
Accounts Payable2.4M1.5M1.8M815K937.3K1.3M
Cash48.5M119.8M57.7M31.4M36.1M48.5M
Non Current Assets Total26.8M28.2M62.4M57.3M65.9M69.2M
Cash And Short Term Investments48.5M207.5M230.2M137.2M157.8M115.7M
Common Stock Shares Outstanding37.1M37.2M39.6M67.2M77.3M41.0M
Liabilities And Stockholders Equity75.9M242.6M299.4M198.1M227.8M151.6M
Non Current Liabilities Total17.4M16.2M35.6M31.8M36.6M18.7M
Other Current Assets567K6.9M6.7M3.6M4.2M3.3M
Other Stockholder Equity2.2M346.4M473.6M490.9M564.5M592.7M
Total Liab27.6M26.3M48.8M47.4M54.5M29.3M
Net Invested Capital(59.1M)216.3M250.6M150.7M173.3M98.8M
Property Plant And Equipment Gross21.8M24.6M61.7M58.2M66.9M70.3M
Total Current Assets49.1M214.4M237.0M140.8M161.9M119.1M
Capital Stock25.1M107.3M4K7K6.3K6.0K
Net Working Capital38.9M204.2M223.8M125.2M144.0M108.3M
Property Plant Equipment728K21.8M6.9M12.6M14.5M9.3M
Non Currrent Assets Other3.4M3.3M2.9M7.2M8.3M8.7M

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.